… Accordingly, in these hiPSC-derived hNPCs and neurons, we observe a shortening of PC. …
human cellular and mouse models of familial PD. Furthermore, in sPD models, the shortening …

… transplantation developed in patients and animal models of Parkinson’s disease, with a focus
on … neurons would serve as a strategy to increase cell survival and improve graft outcomes. …

… of dopamine neurons is altered in Parkinson's disease (PD), … human data and studies in
animal models of PD. We then … to target and protect dopamine neurons from degeneration. …

… SNcDA neurons to switch back to sodium channel use, thus reducing intraneuronal Ca 2+
concentration and energy demand (‘rejuvenation’) [7,13]; this might protect SNcDA neurons …

… Parkinson's disease (PD) is characterized by a myriad of … ABA on cognitive and motor
disorders, a mouse model of PD was … plays a crucial role in protecting mice from motor disabilities …

… animal models, and effects of CDNF and MANF in preclinical … unable to protect neurons
perfectly bound GRP78 (119). … Recently, MANF was associated with rejuvenating effects in …

… as a mixture of viniferin and resveratrol protects neuronal dopaminergic cells from 6-OHDA-…
dopaminergic neuron death recapitulating the pathogenetic features of PD in rodent models …

… -treatment of SWE in the rotenone mice model induced a significant increase in TH
immunoreactivity in the striatum (p < 0.05) and an increase in the number of TH + neurons in SN (p < …

… protected the dopaminergic neurons in the in vivo and vitro … the origin of the rejuvenated
dopaminergic fibers around the … PD mice model, based on the results of the present and previ…

… effects in a mouse model of Parkinson’s disease. In vitro, miR-124-3p-loaded small extracellular
vesicles induced neuronal … We found that miR-124-3p sEVs protect DA neurons from 6-…